DK129514B - Fremgangsmåde til fremstilling af eventuelt 21-substituerede og/eller eventuelt 1(2)-umættede 6,6,9α-trifluor-11β,16α-17α-trihydroxy-4-pregnen-3,20-dion-16,17-ketaler. - Google Patents

Fremgangsmåde til fremstilling af eventuelt 21-substituerede og/eller eventuelt 1(2)-umættede 6,6,9α-trifluor-11β,16α-17α-trihydroxy-4-pregnen-3,20-dion-16,17-ketaler.

Info

Publication number
DK129514B
DK129514B DK463071AA DK463071A DK129514B DK 129514 B DK129514 B DK 129514B DK 463071A A DK463071A A DK 463071AA DK 463071 A DK463071 A DK 463071A DK 129514 B DK129514 B DK 129514B
Authority
DK
Denmark
Prior art keywords
optionally
pregnene
ketals
trihydroxy
dione
Prior art date
Application number
DK463071AA
Other languages
Danish (da)
English (en)
Other versions
DK129514C (es
Inventor
W Ripka
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK129514B publication Critical patent/DK129514B/da
Application granted granted Critical
Publication of DK129514C publication Critical patent/DK129514C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/939Rhizopus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK463071AA 1971-02-01 1971-09-22 Fremgangsmåde til fremstilling af eventuelt 21-substituerede og/eller eventuelt 1(2)-umættede 6,6,9α-trifluor-11β,16α-17α-trihydroxy-4-pregnen-3,20-dion-16,17-ketaler. DK129514B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11161571A 1971-02-01 1971-02-01

Publications (2)

Publication Number Publication Date
DK129514B true DK129514B (da) 1974-10-21
DK129514C DK129514C (es) 1975-03-17

Family

ID=22339486

Family Applications (1)

Application Number Title Priority Date Filing Date
DK463071AA DK129514B (da) 1971-02-01 1971-09-22 Fremgangsmåde til fremstilling af eventuelt 21-substituerede og/eller eventuelt 1(2)-umættede 6,6,9α-trifluor-11β,16α-17α-trihydroxy-4-pregnen-3,20-dion-16,17-ketaler.

Country Status (13)

Country Link
US (1) US3718673A (es)
AT (1) AT308294B (es)
AU (1) AU3452371A (es)
BE (1) BE774754A (es)
CA (1) CA945139A (es)
DE (1) DE2149798A1 (es)
DK (1) DK129514B (es)
ES (1) ES396031A1 (es)
FR (1) FR2124218B1 (es)
GB (3) GB1363458A (es)
IL (1) IL37798A0 (es)
NL (1) NL7113713A (es)
ZA (1) ZA716382B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7502252A (nl) * 1974-02-27 1975-08-29 Pierrel Spa Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden.
US4272446A (en) * 1974-02-27 1981-06-09 Pierrel S.P.A. Steroids and process for preparing the same
DE2655570A1 (de) * 1975-12-12 1977-06-16 Ciba Geigy Ag Neue polyhalogensteroide und verfahren zu ihrer herstellung
ATE18257T1 (de) * 1980-12-23 1986-03-15 Schering Ag Verfahren zur herstellung von 11-beta,21dihydroxy-2'-methyl-5'-beta-h-1,4-pregnadien(16,17)-oxazol-3,20-dion.
CN102061320B (zh) * 2010-12-02 2013-04-03 浙江仙琚制药股份有限公司 11α,17α-二羟基-雄甾-4-烯-3,20-二酮的制备方法
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338928A (en) * 1965-09-09 1967-08-29 Syntex Corp Fused halocyclopropyl steroids
US3546215A (en) * 1967-10-18 1970-12-08 Syntex Corp 6-gem-difluoro steroids

Also Published As

Publication number Publication date
DE2149798A1 (de) 1972-08-03
GB1363460A (en) 1974-08-14
IL37798A0 (en) 1971-11-29
CA945139A (en) 1974-04-09
ZA716382B (en) 1972-07-26
US3718673A (en) 1973-02-27
SU438181A3 (ru) 1974-07-30
DK129514C (es) 1975-03-17
FR2124218B1 (es) 1975-03-14
FR2124218A1 (es) 1972-09-22
ES396031A1 (es) 1975-02-16
BE774754A (fr) 1972-05-02
AT308294B (de) 1973-06-25
NL7113713A (es) 1972-08-03
GB1363459A (en) 1974-08-14
AU3452371A (en) 1973-04-19
GB1363458A (en) 1974-08-14

Similar Documents

Publication Publication Date Title
DK135047B (da) Analogifremgangsmåde til fremstilling af 11,11-alkylidensteroider af estran- eller 19-norpregnanrækken.
DK133986B (da) Analogifremgangsmåde til fremstilling af 5-(1-oxo-5-indanyloxy)-tetrazoler eller 5-(1-oxo-5-indanyloxymethyl)-tetrazoler.
DK126787B (da) Fremgangsmåde til fremstilling af N<6>-substituerede adenosiner.
DK129514B (da) Fremgangsmåde til fremstilling af eventuelt 21-substituerede og/eller eventuelt 1(2)-umættede 6,6,9α-trifluor-11β,16α-17α-trihydroxy-4-pregnen-3,20-dion-16,17-ketaler.
DK130225B (da) Fremgangsmåde til fremstilling af antibiotiket 23.671 RP og antibiotiket 23.672 RP.
DK136218B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxysteroider af pregnan- eller 19-norpregnanrækken.
DK138229B (da) Fremgangsmåde til fremstilling af (+)(-)-eburnamonin.
DK131036B (da) Analogifremgangsmåde til fremstilling af 3,16alfa,17xi-trihydroxy-11beta-alkoxyestra-1,3,5(10)-triener.
IS2050A7 (is) Efni afleidd úr acyli og aðferð til að framleiða þau.
DK134486B (da) Analogifremgangsmåde til fremstilling af 3-hydrazonomethyl-rifamycin-derivater eller 25-desacetyl- eller 16, 17, 18, 19, 28, 29-hexahydroderivater deraf.
DK132221B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK131296B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-19-nor-5alfa-pregnan-11,20-dion.
DK128738B (da) Analogifremgangsmåde til fremstilling af cardenolid- eller bufadienolid-3-[2',3'-didesoxyglycosider].
DK130957B (da) Fremgangsmåde til fremstilling af pregnanderivater.
DK128736B (da) Analogifremgangsmåde til fremstilling af 3,17β-dialkoxy-estra-1,3,5(10)-triener.
DK133682B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-5alfa-pregn-1-en-20-oner eller 3alfa-hydroxy-17beta-alkoxykarbonyl-5alfa-androst-1-ener.
DK129794B (da) Analogifremgangsmåde til fremstilling af N-acyl-3-(piperazinoethyl)-pyrazoler.
DK130792B (da) Fremgangsmåde til fremstilling af cis-zearalenon eller cis-zearalenol.
DK130308B (da) Fremgangsmåde til fremstilling af 13β-alkylgona-4,9,11-triener.
DK129345B (da) Analogifremgangsmåde til fremstilling af 22-fluor-3'''-acyldigoxiner.
DK131473B (da) Analogifremgangsmåde til fremstilling af 3,17beta-dihydroxy-11alfa-alkoxy-13beta-alkylgona-1,3,5(10)-triener.
DK126036B (da) Analogifremgangsmåde til frmstilling af 3-oxo-13β-ethyl-7α, 17α-dimethyl-17β-hydroxy-4,9,11-gonatrien eller estere deraf.
DK129123B (da) Analogifremgangsmåde til fremstilling af 16β-karbonhydridsubstituerede estr-4-en- eller estr-5(10)-en-3-on-17β-oler eller estere eller ætere deraf.
DK132440C (da) Analogifremgangsmade til fremstilling af 11-oxygenerede 2-chlor-6alfa,9alfa-difluor-16alfa-methyl-3,20,21-trioxo-1,4-pregnadiener eller 21-aldehydhydrater, -estere eller -acetaler deraf
DK131189B (da) Analogifremgangsmåde til fremstilling af 16-hydroxylerede 17alfa-ethynyl-17beta-hydroxy-13beta-alkylgona-4,9,11-trien-3-oner.